Standards for foreign clinical studies not conducted under an investigational new drug application (IND) as support for an IND or application for marketing approval for a drug or biological product have been updated by the FDA. The FDA will replace the requirement that foreign studies be conducted in accordance with the ethical principles stated in the Declaration of Helsinki with a requirement that the studies be conducted in accordance with good clinical practice, including review and approval by an independent ethics committee.
SOURCE: FDA Order
For more information on this and related topics, consult the CCH Food, Drug and Cosmetic Law Reporter.
Visit our News Library to read more news stories.
Food, Drug and Cosmetics Law Reporter
Everything you need to know about Food and Drug Regulations.Full-text source covering federal and state laws and regulations and court decisions that govern the safety, effectiveness, purity, packaging and labeling of food, drugs and cosmetics. Learn More » |
Medical Devices ReporterAccess the full text plus expert analysis of all laws and regulations governing the classification, approval, manufacture, and marketing of all medical diagnostic, and radiological devices. Learn More »
|